When cells were treated with both IFN-α and an IFNAR blocking antibody, the cells became vulnerable to VSVΔ51 infection, demonstrating that the concentration range of IFNAR blocking antibody was sufficient to block the binding and engagement of IFNAR ligands. The gene discussed is IFNA1; the disease is infection.